| James W Nichols, DO | |
|
1112 Mill Street, Camden, SC 29020 | |
| (803) 432-4498 | |
| (803) 425-4123 |
| Full Name | James W Nichols |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 52 Years |
| Location | 1112 Mill Street, Camden, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194754713 | NPI | - | NPPES |
| 001287 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 0128 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kershawhealth | Camden, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Camden Bone And Joint Llc | 3375448442 | 4 |
News Archive
A new study suggests that your breakfast cereal choice may affect how full you feel and how much you eat for lunch, especially if you're overweight. According to new research published in the latest issue of the Annals of Nutrition and Metabolism, scientists found that having oatmeal (Quaker Oats Quick 1-minute™) for breakfast resulted in greater fullness, lower hunger ratings and fewer calories eaten at the next meal compared to a calorie-matched breakfast of a ready-to-eat cereal (RTEC) - sugared corn flakes.
At Medica 2016, SYMILA, the Fraunhofer Application Center at Hamm, will demo a telemedicine Internet portal for diabetics, which was implemented on behalf of DITG - Deutsches Institut für Telemedizin und Gesundheitsförderung.
Challenge Dementia, supported by Nesta, launches today as the first national search for next generation products, technologies and services that could transform the way people live with dementia helping them to live enjoyable and fulfilling lives for as long as possible.
Forest Laboratories, Inc. (NYSE: FRX) and Glenmark Pharmaceuticals S.A. (Switzerland), a wholly owned subsidiary of Glenmark Pharmaceuticals India (GPL) today announced top-line results from a Phase IIb dose range-finding study of oglemilast in patients with Chronic Obstructive Pulmonary Disease (COPD). Once-daily treatment with oglemilast did not show a statistically meaningful increase from baseline compared to placebo in the primary endpoint trough FEV1, a measure of pulmonary function that is decreased in patients with COPD. Oglemilast was well tolerated at all doses studied.
› Verified 3 days ago
| Entity Name | Camden Bone & Joint Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497783880 PECOS PAC ID: 3375448442 Enrollment ID: O20031203000008 |
News Archive
A new study suggests that your breakfast cereal choice may affect how full you feel and how much you eat for lunch, especially if you're overweight. According to new research published in the latest issue of the Annals of Nutrition and Metabolism, scientists found that having oatmeal (Quaker Oats Quick 1-minute™) for breakfast resulted in greater fullness, lower hunger ratings and fewer calories eaten at the next meal compared to a calorie-matched breakfast of a ready-to-eat cereal (RTEC) - sugared corn flakes.
At Medica 2016, SYMILA, the Fraunhofer Application Center at Hamm, will demo a telemedicine Internet portal for diabetics, which was implemented on behalf of DITG - Deutsches Institut für Telemedizin und Gesundheitsförderung.
Challenge Dementia, supported by Nesta, launches today as the first national search for next generation products, technologies and services that could transform the way people live with dementia helping them to live enjoyable and fulfilling lives for as long as possible.
Forest Laboratories, Inc. (NYSE: FRX) and Glenmark Pharmaceuticals S.A. (Switzerland), a wholly owned subsidiary of Glenmark Pharmaceuticals India (GPL) today announced top-line results from a Phase IIb dose range-finding study of oglemilast in patients with Chronic Obstructive Pulmonary Disease (COPD). Once-daily treatment with oglemilast did not show a statistically meaningful increase from baseline compared to placebo in the primary endpoint trough FEV1, a measure of pulmonary function that is decreased in patients with COPD. Oglemilast was well tolerated at all doses studied.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James W Nichols, DO 1112 Mill St, Camden, SC 29020-3712 Ph: (803) 432-4498 | James W Nichols, DO 1112 Mill Street, Camden, SC 29020 Ph: (803) 432-4498 |
News Archive
A new study suggests that your breakfast cereal choice may affect how full you feel and how much you eat for lunch, especially if you're overweight. According to new research published in the latest issue of the Annals of Nutrition and Metabolism, scientists found that having oatmeal (Quaker Oats Quick 1-minute™) for breakfast resulted in greater fullness, lower hunger ratings and fewer calories eaten at the next meal compared to a calorie-matched breakfast of a ready-to-eat cereal (RTEC) - sugared corn flakes.
At Medica 2016, SYMILA, the Fraunhofer Application Center at Hamm, will demo a telemedicine Internet portal for diabetics, which was implemented on behalf of DITG - Deutsches Institut für Telemedizin und Gesundheitsförderung.
Challenge Dementia, supported by Nesta, launches today as the first national search for next generation products, technologies and services that could transform the way people live with dementia helping them to live enjoyable and fulfilling lives for as long as possible.
Forest Laboratories, Inc. (NYSE: FRX) and Glenmark Pharmaceuticals S.A. (Switzerland), a wholly owned subsidiary of Glenmark Pharmaceuticals India (GPL) today announced top-line results from a Phase IIb dose range-finding study of oglemilast in patients with Chronic Obstructive Pulmonary Disease (COPD). Once-daily treatment with oglemilast did not show a statistically meaningful increase from baseline compared to placebo in the primary endpoint trough FEV1, a measure of pulmonary function that is decreased in patients with COPD. Oglemilast was well tolerated at all doses studied.
› Verified 3 days ago
Thomas N Joseph, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1112 Mill St, Camden, SC 29020 Phone: 803-432-4498 Fax: 803-425-4123 | |
Tuan Christopher Tran, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1112 Mill St, L, Camden, SC 29020 Phone: 803-432-4498 Fax: 803-425-4123 |